Question follow-through · 128119
NHS: Agency Staff
To ask the Secretary of State for Health and Social Care, what discussions his Department has had with NHS England and NHS workforce framework providers on ensuring compliant payroll practices within the agency staffing supply chains for the NHS.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 17 Apr 2026
- Target answer date
- 21 Apr 2026
- Answer
- 29 Apr 2026 · 12 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
17 Apr 2026
Question tabled
To ask the Secretary of State for Health and Social Care, what discussions his Department has had with NHS England and NHS workforce framework providers on ensuring compliant payroll practices within the agency staffing supply chains for the NHS.
21 Apr 2026
Target answer date
Date supplied by the official written-questions record.
29 Apr 2026
Answer published
The Department, alongside NHS England, collaborates with framework providers like the NHS Workforce Alliance and HealthTrust Europe to ensure compliant payroll practices. Key actions include mandatory auditing, IR35 compliance, adherence to National Healt...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
No later same-department questions indexed.
This is an absence in covered public data, not evidence that no follow-up occurred elsewhere.